EFSA Finds Food Enzyme Safety Gaps in Assessment

The European Food Safety Authority's panel reviewed a Trichoderma reesei-derived enzyme used in nine food manufacturing processes.

Updated on Nov. 17, 2026 in Nutrition

Isometric editorial illustration of a single stainless fermentation vessel holding amber liquid beside a sample flask in a bare industrial hall.
The European Food Safety Authority's expert panel said it cannot yet clear a Novozymes-made enzyme used in nine food manufacturing processes, citing missing toxicology data. AI Illustration. Upload story photo >

The EFSA Panel on Food Enzymes assessed a food enzyme containing cellulase, endo-1,3(4)-β-glucanase and endo-1,4-β-xylanase activities, produced by Novozymes A/S using the non-genetically modified Trichoderma reesei strain NZYM-TV. The panel could not conclude on genotoxicity or systemic toxicity because no studies on the enzyme under assessment were available.

Why it matters

The enzyme is intended for use in nine food manufacturing processes, so the assessment bears on the ingredients used across a range of processed foods consumed in Europe. The gaps in toxicological data mean regulators cannot yet fully characterize the safety profile of the enzyme as produced.

Estimated dietary exposure reaches up to 0.177 mg TOS/kg body weight per day across European populations, based on seven processes after residual removal in two of nine. The Panel cannot exclude a low-likelihood allergic reaction risk, and toxicity conclusions remain open because the supporting studies used a substitute enzyme.

The players

European Food Safety Authority (EFSA)

The EFSA is the European Union agency that provides independent scientific advice on risks in the food chain.

Novozymes A/S

Novozymes A/S is a Danish biotechnology company that produces industrial enzymes, including the food enzyme assessed by the panel.

The details

The Panel evaluated the enzyme, which Novozymes A/S produces with the non-genetically modified Trichoderma reesei strain NZYM-TV, and found the food enzyme free from viable cells of the production organism. A homology search of its amino acid sequences against known allergens found no match, though the Panel said a risk of allergic reactions cannot be excluded.

Timeline

  1. Article reporting the EFSA assessment was published on November 17, 2026.

Nutrition Context

The opinion follows EFSA's established food enzyme evaluation process, which requires direct toxicological data on the specific enzyme under review. Where such data are missing, as with the substitute-enzyme studies here, the Panel declines to draw safety conclusions.

Consumers of processed foods made with this enzyme are unlikely to see a direct change, since the opinion does not itself alter product labeling or approvals. Those with known sensitivities to fungal-derived ingredients should note that the Panel could not fully exclude allergic reactions.

The takeaway

Regulatory safety opinions on food ingredients are only as complete as the toxicological data behind them. When studies use substitute products, the resulting conclusions may not apply to the product actually sold.

Further reading

For more on how additives and processing aids are regulated, explore Nutrition coverage.

Source note: This article includes information reported by Foodmate.